Skip to main content
Premium Trial:

Request an Annual Quote

Panomics Opens European Subsidiary in Italy

NEW YORK, April 25 (GenomeWeb News) - Reagent company Panomics today said it has opened a wholly owned European subsidiary, Panomics SRL, located in Milan, Italy.

 

"There is substantial customer demand for Panomics' products in Europe," George Bers, executive vice president for commercial operations at Panomics, said in a statement.

 

Bio-Rad alumni Luigi Pirovano has been named managing director of the new unit.

 

Panomics is a provider of research reagents for transcription regulation, cell signaling, and signal transduction. As GenomeWeb News reported, Genospectra acquired Panomics  in February.

 

The combined company, which was renamed Panomics, plays in markets including cell signaling, RNAi-mediated gene silencing and high performance assays, clinical biomarker discovery, and predictive toxicology.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.